Prevalence and Childhood Precursors of Opioid Use in the Early Decades of Life | Adolescent Medicine | JN Learning | AMA Ed Hub [Skip to Content]
[Skip to Content Landing]

Prevalence and Childhood Precursors of Opioid Use in the Early Decades of Life

Educational Objective
To document age-related changes in opioid use and study the childhood antecedents of opioid use by age 30 years in 6 domains of childhood risk: sociodemographic characteristics; school or peer problems; parental mental illness, drug problems, or legal involvement; substance use; psychiatric illness; and physical health.
1 Credit CME
Key Points

Question  How common is opioid use in the early decades of life, and which childhood risk factors are associated with opioid use in young adulthood?

Findings  This cohort study assessed opioid use among 1252 non-Hispanic White individuals and American Indian individuals in rural counties in the central Appalachia region of North Carolina from January 1993 to December 2015. By age 30 years, approximately one-quarter of participants had used opioids, and the findings revealed that childhood tobacco use and depression were associated with later nonheroin opioid use in general, weekly nonheroin opioid use, and heroin use.

Meaning  Childhood tobacco use and depression may be associated with impaired reward system functioning, which may increase young adults’ vulnerability to opioid-associated euphoria.

Abstract

Importance  Opioid use disorder and opioid deaths have increased dramatically in young adults in the US, but the age-related course or precursors to opioid use among young people are not fully understood.

Objective  To document age-related changes in opioid use and study the childhood antecedents of opioid use by age 30 years in 6 domains of childhood risk: sociodemographic characteristics; school or peer problems; parental mental illness, drug problems, or legal involvement; substance use; psychiatric illness; and physical health.

Design, Setting, and Participants  This community-representative prospective longitudinal cohort study assessed 1252 non-Hispanic White individuals and American Indian individuals in rural counties in the central Appalachia region of North Carolina from January 1993 to December 2015. Data were analyzed from January 2019 to January 2020.

Exposures  Between ages 9 and 16 years, participants and their parents were interviewed up to 7 times using the Child and Adolescent Psychiatric Assessment and reported risk factors in 6 risk domains.

Main Outcomes and Measures  Participants were assessed again at ages 19, 21, 25, and 30 years for nonheroin opioid use (any and weekly) and heroin use using the structured Young Adult Psychiatric Assessment.

Results  Of 1252 participants, 342 (27%) were American Indian. By age 30 years, 322 participants had used a nonheroin opioid (24.2%; 95% CI, 21.8-26.5), 155 had used a nonheroin opioid weekly (8.8%; 95% CI, 7.2-10.3), and 95 had used heroin (6.6%; 95% CI, 5.2-7.9). Childhood risk markers for later opioid use included male sex, tobacco use, depression, conduct disorder, cannabis use, having peers exhibiting social deviance, parents with legal involvement, and elevated systemic inflammation. In final models, childhood tobacco use, depression, and cannabis use were most robustly associated with opioid use in young adulthood (ages 19 to 30 years). Chronic depression and dysthymia were strongly associated with any nonheroin opioid use (OR. 5.43; 95% CI, 2.35-12.55 and OR, 7.13; 95% CI, 1.99-25.60, respectively) and with weekly nonheroin opioid use (OR, 8.89; 95% CI, 3.61-21.93 and OR, 11.51; 95% CI, 3.05-42.72, respectively). Among young adults with opioid use, those with heroin use had the highest rates of childhood psychiatric disorders and comorbidities.

Conclusions and Relevance  Childhood tobacco use and chronic depression may be associated with impaired reward system functioning, which may increase young adults’ vulnerability to opioid-associated euphoria. Preventing and treating early substance use and childhood mental illness may help prevent later opioid use.

Sign in to take quiz and track your certificates

Buy This Activity

JN Learning™ is the home for CME and MOC from the JAMA Network. Search by specialty or US state and earn AMA PRA Category 1 CME Credit™ from articles, audio, Clinical Challenges and more. Learn more about CME/MOC

Article Information

Accepted for Publication: July 20, 2020.

Published Online: December 28, 2020. doi:10.1001/jamapediatrics.2020.5205

Open Access: This is an open access article distributed under the terms of the CC-BY License. © 2020 Shanahan L et al. JAMA Pediatrics.

Corresponding Author: Lilly Shanahan, PhD, Jacobs Center for Productive Youth Development, University of Zurich, Andreasstrasse 15, PO Box 12, CH-8050 Zurich, Switzerland (lilly.shanahan@jacobscenter.uzh.ch).

Author Contributions: Dr Shanahan had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.

Concept and design: Shanahan, Hill, Godwin, Gaydosh, Harris, Copeland.

Acquisition, analysis, or interpretation of data: Shanahan, Bechtiger, Steinhoff, Godwin, Gaydosh, Harris, Dodge, Copeland.

Drafting of the manuscript: Shanahan.

Critical revision of the manuscript for important intellectual content: All authors.

Statistical analysis: Shanahan, Godwin.

Obtained funding: Shanahan, Harris, Dodge, Copeland.

Administrative, technical, or material support: Bechtiger, Steinhoff, Harris, Copeland.

Conflict of Interest Disclosures: None reported.

Funding/Support: This research was supported by the National Institute of Mental Health (grant R01MH117559) and the National Institute on Drug Abuse (grants R01DA036523 and R01DA11301).

Role of the Funder/Sponsor: The funders had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.

Disclaimer: The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.

References
1.
Kolodny  A , Courtwright  DT , Hwang  CS ,  et al.  The prescription opioid and heroin crisis: a public health approach to an epidemic of addiction.   Annu Rev Public Health. 2015;36:559-574. doi:10.1146/annurev-publhealth-031914-122957PubMedGoogle ScholarCrossref
2.
Quinones  S.   Dreamland: The True Tale of America's Opiate Epidemic. Bloomsbury Press; 2016.
3.
McCabe  SE , Veliz  P , Wilens  TE ,  et al.  Sources of nonmedical prescription drug misuse among US high school seniors: differences in motives and substance use behaviors.   J Am Acad Child Adolesc Psychiatry. 2019;58(7):681-691. doi:10.1016/j.jaac.2018.11.018PubMedGoogle ScholarCrossref
4.
Ford  JA , Pomykacz  C , Szalewski  A , McCabe  SE , Schepis  TS .  Friends and relatives as sources of prescription opioids for misuse among young adults: the significance of physician source and race/ethnic differences.   Subst Abus. 2020;41(1):93-100. doi:10.1080/08897077.2019.1635955PubMedGoogle ScholarCrossref
5.
Jones  CM , Paulozzi  LJ , Mack  KA .  Sources of prescription opioid pain relievers by frequency of past-year nonmedical use: United States, 2008-2011.   JAMA Intern Med. 2014;174(5):802-803. doi:10.1001/jamainternmed.2013.12809PubMedGoogle ScholarCrossref
6.
Haegerich  TM , Jones  CM , Cote  PO , Robinson  A , Ross  L .  Evidence for state, community and systems-level prevention strategies to address the opioid crisis.   Drug Alcohol Depend. 2019;204:107563. doi:10.1016/j.drugalcdep.2019.107563PubMedGoogle Scholar
7.
Haegerich  TM , Paulozzi  LJ , Manns  BJ , Jones  CM .  What we know, and don’t know, about the impact of state policy and systems-level interventions on prescription drug overdose.   Drug Alcohol Depend. 2014;145:34-47. doi:10.1016/j.drugalcdep.2014.10.001PubMedGoogle ScholarCrossref
8.
Trust for America's Health and Well Being Trust. Alcohol and drug misuse and suicide and the millennial generation—a devastating impact. Accessed February 1, 2020. https://www.tfah.org/wp-content/uploads/2019/06/TFAH2019_YoungAdult_PainBrief_FINAL.pdf
9.
Martins  SS , Segura  LE , Santaella-Tenorio  J ,  et al.  Prescription opioid use disorder and heroin use among 12-34 year-olds in the United States from 2002 to 2014.   Addict Behav. 2017;65:236-241. doi:10.1016/j.addbeh.2016.08.033PubMedGoogle ScholarCrossref
10.
Miech  R , Bohnert  A , Heard  K , Boardman  J .  Increasing use of nonmedical analgesics among younger cohorts in the United States: a birth cohort effect.   J Adolesc Health. 2013;52(1):35-41. doi:10.1016/j.jadohealth.2012.07.016PubMedGoogle ScholarCrossref
11.
Woolf  SH , Schoomaker  H .  Life expectancy and mortality rates in the United States, 1959–2017.   JAMA. 2019;322(20):1996-2016. doi:10.1001/jama.2019.16932PubMedGoogle ScholarCrossref
12.
Miech  R , Johnston  L , O’Malley  PM , Keyes  KM , Heard  K .  Prescription opioids in adolescence and future opioid misuse.   Pediatrics. 2015;136(5):e1169-e1177. doi:10.1542/peds.2015-1364PubMedGoogle ScholarCrossref
13.
McCabe  SE , West  BT , Veliz  P , McCabe  VV , Stoddard  SA , Boyd  CJ .  Trends in medical and nonmedical use of prescription opioids among US adolescents: 1976–2015.   Pediatrics. 2017;139(4):e20162387. doi:10.1542/peds.2016-2387PubMedGoogle Scholar
14.
McCabe  SE , Schulenberg  JE , O’Malley  PM , Patrick  ME , Kloska  DD .  Non-medical use of prescription opioids during the transition to adulthood: a multi-cohort national longitudinal study.   Addiction. 2014;109(1):102-110. doi:10.1111/add.12347PubMedGoogle ScholarCrossref
15.
Vaughn  MG , Nelson  EJ , Salas-Wright  CP , Qian  Z , Schootman  M .  Racial and ethnic trends and correlates of non-medical use of prescription opioids among adolescents in the United States 2004-2013.   J Psychiatr Res. 2016;73:17-24. doi:10.1016/j.jpsychires.2015.11.003PubMedGoogle ScholarCrossref
16.
Wall  M , Cheslack-Postava  K , Hu  MC , Feng  T , Griesler  P , Kandel  DB .  Nonmedical prescription opioids and pathways of drug involvement in the US: generational differences.   Drug Alcohol Depend. 2018;182:103-111. doi:10.1016/j.drugalcdep.2017.10.013PubMedGoogle ScholarCrossref
17.
Meier  EA , Troost  JP , Anthony  JC .  Extramedical use of prescription pain relievers by youth aged 12 to 21 years in the United States: national estimates by age and by year.   Arch Pediatr Adolesc Med. 2012;166(9):803-807. doi:10.1001/archpediatrics.2012.209PubMedGoogle ScholarCrossref
18.
Hu  MC , Griesler  P , Wall  M , Kandel  DB .  Age-related patterns in nonmedical prescription opioid use and disorder in the US population at ages 12-34 from 2002 to 2014.   Drug Alcohol Depend. 2017;177:237-243. doi:10.1016/j.drugalcdep.2017.03.024PubMedGoogle ScholarCrossref
19.
Grant  BF , Saha  TD , Ruan  WJ ,  et al.  Epidemiology of DSM-5 drug use disorder: results from the National Epidemiologic Survey on Alcohol and Related Conditions-III.   JAMA Psychiatry. 2016;73(1):39-47. doi:10.1001/jamapsychiatry.2015.2132PubMedGoogle ScholarCrossref
20.
Vaughn  MG , Fu  Q , Perron  BE , Wu  LT .  Risk profiles among adolescent nonmedical opioid users in the United States.   Addict Behav. 2012;37(8):974-977. doi:10.1016/j.addbeh.2012.03.015PubMedGoogle ScholarCrossref
21.
Veliz  P , Epstein-Ngo  QM , Meier  E , Ross-Durow  PL , McCabe  SE , Boyd  CJ .  Painfully obvious: a longitudinal examination of medical use and misuse of opioid medication among adolescent sports participants.   J Adolesc Health. 2014;54(3):333-340. doi:10.1016/j.jadohealth.2013.09.002PubMedGoogle ScholarCrossref
22.
Groenewald  CB , Law  EF , Fisher  E , Beals-Erickson  SE , Palermo  TM .  Associations between adolescent chronic pain and prescription opioid misuse in adulthood.   J Pain. 2019;20(1):28-37. doi:10.1016/j.jpain.2018.07.007PubMedGoogle ScholarCrossref
23.
Cerdá  M , Santaella  J , Marshall  BD , Kim  JH , Martins  SS .  Nonmedical prescription opioid use in childhood and early adolescence predicts transitions to heroin use in young adulthood: a national study.   J Pediatr. 2015;167(3):605-12.e1, 2. doi:10.1016/j.jpeds.2015.04.071PubMedGoogle ScholarCrossref
24.
Reuben  A , Moffitt  TE , Caspi  A ,  et al.  Lest we forget: comparing retrospective and prospective assessments of adverse childhood experiences in the prediction of adult health.   J Child Psychol Psychiatry. 2016;57(10):1103-1112. doi:10.1111/jcpp.12621PubMedGoogle ScholarCrossref
25.
Compton  WM , Lopez  MF .  Accuracy in reporting past psychiatric symptoms: the role of cross-sectional studies in psychiatric research.   JAMA Psychiatry. 2014;71(3):233-234. doi:10.1001/jamapsychiatry.2013.4111PubMedGoogle ScholarCrossref
26.
Meit  M , Heffernan  M , Tanenbaum  E , Hoffmann  T. Final report: Appalachian diseases of despair. Accessed September 14, 2017. https://www.arc.gov/wp-content/uploads/2020/06/AppalachianDiseasesofDespairAugust2017.pdf
27.
Etz  KE , Arroyo  JA , Crump  AD , Rosa  CL , Scott  MS .  Advancing American Indian and Alaska Native substance abuse research: current science and future directions.   Am J Drug Alcohol Abuse. 2012;38(5):372-375. doi:10.3109/00952990.2012.712173PubMedGoogle ScholarCrossref
28.
Volkow  ND , Warren  KR .  Advancing American Indian/Alaska Native substance abuse research.   Am J Drug Alcohol Abuse. 2012;38(5):371. doi:10.3109/00952990.2012.712174 PubMedGoogle ScholarCrossref
29.
Whitesell  NR , Beals  J , Crow  CB , Mitchell  CM , Novins  DK .  Epidemiology and etiology of substance use among American Indians and Alaska Natives: risk, protection, and implications for prevention.   Am J Drug Alcohol Abuse. 2012;38(5):376-382. doi:10.3109/00952990.2012.694527PubMedGoogle ScholarCrossref
30.
Swaim  RC , Stanley  LR .  Substance use among American Indian youths on reservations compared with a national sample of US adolescents.   JAMA Netw Open. 2018;1(1):e180382. doi:10.1001/jamanetworkopen.2018.0382PubMedGoogle Scholar
31.
Shiels  MS , Chernyavskiy  P , Anderson  WF ,  et al.  Trends in premature mortality in the USA by sex, race, and ethnicity from 1999 to 2014: an analysis of death certificate data.   Lancet. 2017;389(10073):1043-1054. doi:10.1016/S0140-6736(17)30187-3PubMedGoogle ScholarCrossref
32.
Costello  EJ , Mustillo  S , Erkanli  A , Keeler  G , Angold  A .  Prevalence and development of psychiatric disorders in childhood and adolescence.   Arch Gen Psychiatry. 2003;60(8):837-844. doi:10.1001/archpsyc.60.8.837PubMedGoogle ScholarCrossref
33.
Costello  EJ , Angold  A , Burns  BJ ,  et al.  The Great Smoky Mountains Study of Youth: goals, design, methods, and the prevalence of DSM-III-R disorders.   Arch Gen Psychiatry. 1996;53(12):1129-1136. doi:10.1001/archpsyc.1996.01830120067012PubMedGoogle ScholarCrossref
34.
Copeland  WE , Angold  A , Shanahan  L , Costello  EJ .  Longitudinal patterns of anxiety from childhood to adulthood: the Great Smoky Mountains Study.   J Am Acad Child Adolesc Psychiatry. 2014;53(1):21-33. doi:10.1016/j.jaac.2013.09.017PubMedGoogle ScholarCrossref
35.
Angold  A , Costello  EJ .  The Child and Adolescent Psychiatric Assessment (CAPA).   J Am Acad Child Adolesc Psychiatry. 2000;39(1):39-48. doi:10.1097/00004583-200001000-00015PubMedGoogle ScholarCrossref
36.
Angold  A , Cox  A , Prendergast  M ,  et al.  The Young Adult Psychiatric Assessment (YAPA). Duke University Medical Center; 1999.
37.
Angold  A , Costello  E , Egger  H.  Diagnostic assessment: structured interviewing. In: Martin  A , Volkmar  FR , eds.  Lewis's Child and Adolescent Psychiatry: A Comprehensive Textbook. 4th ed. Lippincott, Williams & Wilkins; 2007:344-356.
38.
Angold  A , Erkanli  A , Copeland  W , Goodman  R , Fisher  PW , Costello  EJ .  Psychiatric diagnostic interviews for children and adolescents: a comparative study.   J Am Acad Child Adolesc Psychiatry. 2012;51(5):506-517. doi:10.1016/j.jaac.2012.02.020PubMedGoogle ScholarCrossref
39.
Angold  A , Costello  EJ .  A test-retest reliability study of child-reported psychiatric symptoms and diagnoses using the Child and Adolescent Psychiatric Assessment (CAPA-C).   Psychol Med. 1995;25(4):755-762. doi:10.1017/S0033291700034991PubMedGoogle ScholarCrossref
40.
Shanahan  L , Copeland  WE , Worthman  CM , Erkanli  A , Angold  A , Costello  EJ .  Sex-differentiated changes in C-reactive protein from ages 9 to 21: the contributions of BMI and physical/sexual maturation.   Psychoneuroendocrinology. 2013;38(10):2209-2217. doi:10.1016/j.psyneuen.2013.04.010PubMedGoogle ScholarCrossref
41.
Karshikoff  B , Jensen  KB , Kosek  E ,  et al.  Why sickness hurts: a central mechanism for pain induced by peripheral inflammation.   Brain Behav Immun. 2016;57:38-46. doi:10.1016/j.bbi.2016.04.001PubMedGoogle ScholarCrossref
42.
Dantzer  R , O’Connor  JC , Freund  GG , Johnson  RW , Kelley  KW .  From inflammation to sickness and depression: when the immune system subjugates the brain.   Nat Rev Neurosci. 2008;9(1):46-56. doi:10.1038/nrn2297PubMedGoogle ScholarCrossref
43.
Angold  A , Fisher  PW . Interviewer-based interviews. In: Shaffer  D , Lucas  C , Richters  J , eds.  Diagnostic Assessment in Child and Adolescent Psychopathology. Guilford Press; 1999:34-64.
44.
Pickles  A , Dunn  G , Vázquez-Barquero  JL .  Screening for stratification in two-phase (‘two-stage’) epidemiological surveys.   Stat Methods Med Res. 1995;4(1):73-89. doi:10.1177/096228029500400106PubMedGoogle ScholarCrossref
45.
Shelton  RC , Davidson  J , Yonkers  KA ,  et al.  The undertreatment of dysthymia.   J Clin Psychiatry. 1997;58(2):59-65. doi:10.4088/JCP.v58n0202PubMedGoogle ScholarCrossref
46.
Kendler  KS , Prescott  CA , Myers  J , Neale  MC .  The structure of genetic and environmental risk factors for common psychiatric and substance use disorders in men and women.   Arch Gen Psychiatry. 2003;60(9):929-937. doi:10.1001/archpsyc.60.9.929PubMedGoogle ScholarCrossref
47.
Swendsen  JD , Merikangas  KR .  The comorbidity of depression and substance use disorders.   Clin Psychol Rev. 2000;20(2):173-189. doi:10.1016/S0272-7358(99)00026-4PubMedGoogle ScholarCrossref
48.
Lai  HM , Cleary  M , Sitharthan  T , Hunt  GE .  Prevalence of comorbid substance use, anxiety and mood disorders in epidemiological surveys, 1990-2014: a systematic review and meta-analysis.   Drug Alcohol Depend. 2015;154:1-13. doi:10.1016/j.drugalcdep.2015.05.031PubMedGoogle ScholarCrossref
49.
Zale  EL , Dorfman  ML , Hooten  WM , Warner  DO , Zvolensky  MJ , Ditre  JW .  Tobacco smoking, nicotine dependence, and patterns of prescription opioid misuse: results from a nationally representative sample.   Nicotine Tob Res. 2015;17(9):1096-1103. doi:10.1093/ntr/ntu227PubMedGoogle ScholarCrossref
50.
Skurtveit  S , Furu  K , Selmer  R , Handal  M , Tverdal  A .  Nicotine dependence predicts repeated use of prescribed opioids: prospective population-based cohort study.   Ann Epidemiol. 2010;20(12):890-897. doi:10.1016/j.annepidem.2010.03.010PubMedGoogle ScholarCrossref
51.
Douglas  KR , Chan  G , Gelernter  J ,  et al.  Adverse childhood events as risk factors for substance dependence: partial mediation by mood and anxiety disorders.   Addict Behav. 2010;35(1):7-13. doi:10.1016/j.addbeh.2009.07.004PubMedGoogle ScholarCrossref
52.
Keyes  KM , Gary  D , O’Malley  PM , Hamilton  A , Schulenberg  J .  Recent increases in depressive symptoms among US adolescents: trends from 1991 to 2018.   Soc Psychiatry Psychiatr Epidemiol. 2019;54(8):987-996. doi:10.1007/s00127-019-01697-8PubMedGoogle ScholarCrossref
53.
Khantzian  EJ .  The self-medication hypothesis of substance use disorders: a reconsideration and recent applications.   Harv Rev Psychiatry. 1997;4(5):231-244. doi:10.3109/10673229709030550PubMedGoogle ScholarCrossref
54.
Edlund  MJ , Forman-Hoffman  VL , Winder  CR ,  et al.  Opioid abuse and depression in adolescents: results from the National Survey on Drug Use and Health.   Drug Alcohol Depend. 2015;152:131-138. doi:10.1016/j.drugalcdep.2015.04.010PubMedGoogle ScholarCrossref
55.
Young  A , McCabe  SE , Cranford  JA , Ross-Durow  P , Boyd  CJ .  Nonmedical use of prescription opioids among adolescents: subtypes based on motivation for use.   J Addict Dis. 2012;31(4):332-341. doi:10.1080/10550887.2012.735564PubMedGoogle ScholarCrossref
56.
Boyd  CJ , Young  A , McCabe  SE .  Psychological and drug abuse symptoms associated with nonmedical use of opioid analgesics among adolescents.   Subst Abus. 2014;35(3):284-289. doi:10.1080/08897077.2014.928660PubMedGoogle ScholarCrossref
57.
Baskin-Sommers  AR , Foti  D .  Abnormal reward functioning across substance use disorders and major depressive disorder: considering reward as a transdiagnostic mechanism.   Int J Psychophysiol. 2015;98(2, pt 2):227-239. doi:10.1016/j.ijpsycho.2015.01.011PubMedGoogle ScholarCrossref
58.
Cicero  TJ , Ellis  MS .  Understanding the demand side of the prescription opioid epidemic: does the initial source of opioids matter?   Drug Alcohol Depend. 2017;173(suppl 1):S4-S10. doi:10.1016/j.drugalcdep.2016.03.014PubMedGoogle ScholarCrossref
59.
Angold  A , Erkanli  A , Farmer  EMZ ,  et al.  Psychiatric disorder, impairment, and service use in rural African American and white youth.   Arch Gen Psychiatry. 2002;59(10):893-901. doi:10.1001/archpsyc.59.10.893PubMedGoogle ScholarCrossref
60.
Angold  A , Messer  SC , Stangl  D , Farmer  EMZ , Costello  EJ , Burns  BJ .  Perceived parental burden and service use for child and adolescent psychiatric disorders.   Am J Public Health. 1998;88(1):75-80. doi:10.2105/AJPH.88.1.75PubMedGoogle ScholarCrossref
61.
Mojtabai  R , Olfson  M , Han  B .  National trends in the prevalence and treatment of depression in adolescents and young adults.   Pediatrics. 2016;138(6):e20161878. doi:10.1542/peds.2016-1878PubMedGoogle Scholar
62.
Copeland  WE , Shanahan  L , Davis  M , Burns  BJ , Angold  A , Costello  EJ .  Increase in untreated cases of psychiatric disorders during the transition to adulthood.   Psychiatr Serv. 2015;66(4):397-403. doi:10.1176/appi.ps.201300541PubMedGoogle ScholarCrossref
63.
Lu  CY , Zhang  F , Lakoma  MD ,  et al.  Changes in antidepressant use by young people and suicidal behavior after FDA warnings and media coverage: quasi-experimental study.   BMJ. 2014;348:g3596. doi:10.1136/bmj.g3596PubMedGoogle ScholarCrossref
64.
Admon  R , Pizzagalli  DA .  Dysfunctional reward processing in depression.   Curr Opin Psychol. 2015;4:114-118. doi:10.1016/j.copsyc.2014.12.011PubMedGoogle ScholarCrossref
65.
Egger  HL , Costello  EJ , Erkanli  A , Angold  A .  Somatic complaints and psychopathology in children and adolescents: stomach aches, musculoskeletal pains, and headaches.   J Am Acad Child Adolesc Psychiatry. 1999;38(7):852-860. doi:10.1097/00004583-199907000-00015PubMedGoogle ScholarCrossref
66.
Shanahan  L , Zucker  N , Copeland  WE , Bondy  CL , Egger  HL , Costello  EJ .  Childhood somatic complaints predict generalized anxiety and depressive disorders during young adulthood in a community sample.   Psychol Med. 2015;45(8):1721-1730. doi:10.1017/S0033291714002840PubMedGoogle ScholarCrossref
67.
Bair  MJ , Robinson  RL , Katon  W , Kroenke  K .  Depression and pain comorbidity: a literature review.   Arch Intern Med. 2003;163(20):2433-2445. doi:10.1001/archinte.163.20.2433PubMedGoogle ScholarCrossref
68.
Han  B , Compton  WM , Blanco  C , Crane  E , Lee  J , Jones  CM .  Prescription opioid use, misuse, and use disorders in U.S. adults: 2015 National Survey on Drug Use and Health.   Ann Intern Med. 2017;167(5):293-301. doi:10.7326/M17-0865PubMedGoogle ScholarCrossref
69.
Mojtabai  R .  National trends in long-term use of prescription opioids.   Pharmacoepidemiol Drug Saf. 2018;27(5):526-534. doi:10.1002/pds.4278PubMedGoogle ScholarCrossref
70.
Case  A , Deaton  A .  Rising morbidity and mortality in midlife among white non-Hispanic Americans in the 21st century.   Proc Natl Acad Sci U S A. 2015;112(49):15078-15083. doi:10.1073/pnas.1518393112PubMedGoogle ScholarCrossref
71.
Shanahan  L , Hill  SN , Gaydosh  LM ,  et al.  Does despair really kill? a roadmap for an evidence-based answer.   Am J Public Health. 2019;109(6):854-858. doi:10.2105/AJPH.2019.305016PubMedGoogle ScholarCrossref
72.
Fiellin  LE , Tetrault  JM , Becker  WC , Fiellin  DA , Hoff  RA .  Previous use of alcohol, cigarettes, and marijuana and subsequent abuse of prescription opioids in young adults.   J Adolesc Health. 2013;52(2):158-163. doi:10.1016/j.jadohealth.2012.06.010PubMedGoogle ScholarCrossref
73.
Counotte  DS , Smit  AB , Pattij  T , Spijker  S .  Development of the motivational system during adolescence, and its sensitivity to disruption by nicotine.   Dev Cogn Neurosci. 2011;1(4):430-443. doi:10.1016/j.dcn.2011.05.010PubMedGoogle ScholarCrossref
74.
Lydon  DM , Wilson  SJ , Child  A , Geier  CF .  Adolescent brain maturation and smoking: what we know and where we’re headed.   Neurosci Biobehav Rev. 2014;45:323-342. doi:10.1016/j.neubiorev.2014.07.003PubMedGoogle ScholarCrossref
75.
Nolley  EP , Kelley  BM .  Adolescent reward system perseveration due to nicotine: studies with methylphenidate.   Neurotoxicol Teratol. 2007;29(1):47-56. doi:10.1016/j.ntt.2006.09.026PubMedGoogle ScholarCrossref
76.
O’Dell  LE .  A psychobiological framework of the substrates that mediate nicotine use during adolescence.   Neuropharmacology. 2009;56(suppl 1):263-278. doi:10.1016/j.neuropharm.2008.07.039PubMedGoogle ScholarCrossref
77.
Vihavainen  T , Relander  TR , Leiviskä  R ,  et al.  Chronic nicotine modifies the effects of morphine on extracellular striatal dopamine and ventral tegmental GABA.   J Neurochem. 2008;107(3):844-854. doi:10.1111/j.1471-4159.2008.05676.xPubMedGoogle ScholarCrossref
78.
McMillan  DM , Tyndale  RF .  Nicotine increases codeine analgesia through the induction of brain CYP2D and central activation of codeine to morphine.   Neuropsychopharmacology. 2015;40(7):1804-1812. doi:10.1038/npp.2015.32PubMedGoogle ScholarCrossref
79.
DiFranza  JR , Rigotti  NA , McNeill  AD ,  et al.  Initial symptoms of nicotine dependence in adolescents.   Tob Control. 2000;9(3):313-319. doi:10.1136/tc.9.3.313PubMedGoogle ScholarCrossref
80.
Kandel  DB , Hu  MC , Griesler  PC , Schaffran  C .  On the development of nicotine dependence in adolescence.   Drug Alcohol Depend. 2007;91(1):26-39. doi:10.1016/j.drugalcdep.2007.04.011PubMedGoogle ScholarCrossref
81.
Goodman  E , Capitman  J .  Depressive symptoms and cigarette smoking among teens.   Pediatrics. 2000;106(4):748-755. doi:10.1542/peds.106.4.748PubMedGoogle ScholarCrossref
82.
Duncan  B , Rees  DI .  Effect of smoking on depressive symptomatology: a reexamination of data from the National Longitudinal Study of Adolescent Health.   Am J Epidemiol. 2005;162(5):461-470. doi:10.1093/aje/kwi219PubMedGoogle ScholarCrossref
83.
Rubinstein  ML , Luks  TL , Dryden  WY , Rait  MA , Simpson  GV .  Adolescent smokers show decreased brain responses to pleasurable food images compared with nonsmokers.   Nicotine Tob Res. 2011;13(8):751-755. doi:10.1093/ntr/ntr046PubMedGoogle ScholarCrossref
84.
Bagot  KS , Wu  R , Cavallo  D , Krishnan-Sarin  S .  Assessment of pain in adolescents: influence of gender, smoking status and tobacco abstinence.   Addict Behav. 2017;67:79-85. doi:10.1016/j.addbeh.2016.12.010PubMedGoogle ScholarCrossref
85.
Mikkonen  P , Leino-Arjas  P , Remes  J , Zitting  P , Taimela  S , Karppinen  J .  Is smoking a risk factor for low back pain in adolescents? a prospective cohort study.   Spine (Phila Pa 1976). 2008;33(5):527-532. doi:10.1097/BRS.0b013e3181657d3cPubMedGoogle ScholarCrossref
86.
McMillan  C , Felmlee  D , Osgood  DW .  Peer influence, friend selection, and gender: how network processes shape adolescent smoking, drinking, and delinquency.   Soc Networks. 2018;55:86-96. doi:10.1016/j.socnet.2018.05.008PubMedGoogle ScholarCrossref
87.
Fu  Q , Heath  AC , Bucholz  KK ,  et al.  Shared genetic risk of major depression, alcohol dependence, and marijuana dependence: contribution of antisocial personality disorder in men.   Arch Gen Psychiatry. 2002;59(12):1125-1132. doi:10.1001/archpsyc.59.12.1125PubMedGoogle ScholarCrossref
88.
Copeland  WE , Hill  S , Costello  EJ , Shanahan  L .  Cannabis use and disorder from childhood to adulthood in a longitudinal community sample with American Indians.   J Am Acad Child Adolesc Psychiatry. 2017;56(2):124-132.e2. doi:10.1016/j.jaac.2016.11.006PubMedGoogle ScholarCrossref
89.
Akee  R , Simeonova  E , Copeland  W , Angold  A , Costello  EJ .  Young adult obesity and household income: effects of unconditional cash transfers.   Am Econ J Appl Econ. 2013;5(2):1-28. doi:10.1257/app.5.2.1PubMedGoogle ScholarCrossref
90.
Madras  BK .  The surge of opioid use, addiction, and overdoses: responsibility and response of the US health care system.   JAMA Psychiatry. 2017;74(5):441-442. doi:10.1001/jamapsychiatry.2017.0163PubMedGoogle ScholarCrossref
91.
Costello  EJ , Erkanli  A , Copeland  W , Angold  A .  Association of family income supplements in adolescence with development of psychiatric and substance use disorders in adulthood among an American Indian population.   JAMA. 2010;303(19):1954-1960. doi:10.1001/jama.2010.621PubMedGoogle ScholarCrossref
92.
Austin  AE , Shanahan  ME , Zvara  BJ .  Association of childhood abuse and prescription opioid use in early adulthood.   Addict Behav. 2018;76:265-269. doi:10.1016/j.addbeh.2017.08.033PubMedGoogle ScholarCrossref
93.
Cerdá  M , Bordelois  P , Keyes  KM ,  et al.  Family ties: maternal-offspring attachment and young adult nonmedical prescription opioid use.   Drug Alcohol Depend. 2014;142:231-238. doi:10.1016/j.drugalcdep.2014.06.026PubMedGoogle ScholarCrossref
94.
Alexander  MJ , Kiang  MV , Barbieri  M .  Trends in Black and White opioid mortality in the United States, 1979–2015.   Epidemiology. 2018;29(5):707-715. doi:10.1097/EDE.0000000000000858PubMedGoogle ScholarCrossref
95.
Perrin  EC .  Promotion of mental health as a key element of pediatric care.   JAMA Pediatr. 2020;174(5):413-415. doi:10.1001/jamapediatrics.2020.0020PubMedGoogle ScholarCrossref
96.
Committee on Psychosocial Aspects of Child and Family Health and Task Force on Mental Health.  The future of pediatrics: mental health competencies for pediatric primary care.   Pediatrics. 2009;124(1):410-421. doi:10.1542/peds.2009-1061PubMedGoogle ScholarCrossref
97.
Wakeman  SE , Rigotti  NA , Chang  Y ,  et al.  Effect of integrating substance use disorder treatment into primary care on inpatient and emergency department utilization.   J Gen Intern Med. 2019;34(6):871-877. doi:10.1007/s11606-018-4807-xPubMedGoogle ScholarCrossref
98.
Chua  KP , Brummett  CM , Conti  RM , Bohnert  A .  Association of opioid prescribing patterns with prescription opioid overdose in adolescents and young adults.   JAMA Pediatr. 2019;174(2):141-148. doi:10.1001/jamapediatrics.2019.4878 PubMedGoogle ScholarCrossref
If you are not a JN Learning subscriber, you can either:
Subscribe to JN Learning for one year
Buy this activity
jn-learning_Modal_Multimedia_LoginSubscribe_Purchase
Close
If you are not a JN Learning subscriber, you can either:
Subscribe to JN Learning for one year
Buy this activity
jn-learning_Modal_Multimedia_LoginSubscribe_Purchase
Close
With a personal account, you can:
  • Access free activities and track your credits
  • Personalize content alerts
  • Customize your interests
  • Fully personalize your learning experience
Education Center Collection Sign In Modal Right
Close

Name Your Search

Save Search
Close
With a personal account, you can:
  • Track your credits
  • Personalize content alerts
  • Customize your interests
  • Fully personalize your learning experience
jn-learning_Modal_SaveSearch_NoAccess_Purchase
Close

Lookup An Activity

or

Close

My Saved Searches

You currently have no searches saved.

Close
With a personal account, you can:
  • Access free activities and track your credits
  • Personalize content alerts
  • Customize your interests
  • Fully personalize your learning experience
Education Center Collection Sign In Modal Right
Close